Rapid effect of osimertinib re‑challenge on brain metastases developing during salvage cytotoxic chemotherapy after osimertinib treatment failure: A case report-Reference-Cited by-同舟云学术

Rapid effect of osimertinib re‑challenge on brain metastases developing during salvage cytotoxic chemotherapy after osimertinib treatment failure: A case report

Published:2019-02-27 Issue: Volume: Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:mol clin onc

Author:

Sekine Akimasa¹,Satoh Hiroaki²,Ikeda Satoshi¹,Oda Tsuneyuki¹,Okudela Koji³,Iwasawa Tae⁴,Ogura Takashi¹

Affiliation:

1. Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa 236‑0051, Japan

2. Department of Internal Medicine, Mito Medical Center, University of Tsukuba, Tsukuba, Ibaraki 310‑0015, Japan

3. Department of Pathology, Graduate School of Medicine, Yokohama City University, Yokohama, Kanagawa 236‑0004, Japan

4. Department of Radiology, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa 236‑0051, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osimertinib readministration for central nervous system metastases in non–small cell lung cancer positive for EGFR activating mutations;Respiratory Investigation;2024-05

2. Radiation-induced cognitive toxicity in era of precision oncology – from pathophysiology to strategies for limiting toxicities;Česká a slovenská neurologie a neurochirurgie;2023-10-31

3. Real-World Data About Treatment Outcomes for Patients with EGFR-Mutated NSCLC Resistance to Osimertinib and Platinum-Based Chemotherapy;Advances in Therapy;2023-08-12

4. ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer;Annals of Oncology;2022-05

5. Systematic analysis of the potential off-target activities of osimertinib by computational target fishing;Anti-Cancer Drugs;2021-08-27